The list below is a sampling of the many open BMT clinical trials at University of Minnesota Medical Center. Click on the highlighted links below for a printable pdf summary of selected studies. We will be adding new summaries in the future, so please be sure to visit us again. For information on additional trials, please call 612-273-2800.

Hodgkin’s Lymphoma

Auto Transplant for Lymphoma (MT2004-24)

Reduced Intensity UCB Transplant (MT2005-02)
     Patient Version: Reduced Intensity Umbilical Cord Blood Transplantation (2005-02)

Unrelated Donor Reduced Intensity UCB Transplant for Heme Malignancy (MT2008-30)

Reduced Intensity Allo Bone Marrow Transplant (2001-10)

Myeloablative UCB Transplant for Heme Malignancy (MT2005-10)
     Patient Version: Myeloablative Umbilical Cord Blood Transplantation (2005-10)

Unrelated or Partially Matched Related Donor Transplant for Lymphoma, Myeloma, & CLL (MT1999-14)

CpG after Auto Transplant (MT2003-03)

Expanded Human Myeloid Progenitor Cells post Allo UCB for Heme Malignancy (MT2008-38)

Non-Hodgkin’s Lymphoma

Auto Transplant for Lymphoma (MT2004-24)

Reduced Intensity Allo Bone Marrow Transplant (2001-10)

Reduced Intensity Allo Transplant for Relapsed Follicular NHL (MT2008-42)

Reduced Intensity UCB Transplant (MT2005-02)
     Patient Version: Reduced Intensity Umbilical Cord Blood Transplantation (2005-02)

Unrelated Donor Reduced Intensity UCB Transplant for Heme Malignancy (MT2008-30)

Myeloablative UCB Transplant for Heme Malignancy (MT2005-10)
     Patient Version: Myeloablative Umbilical Cord Blood Transplantation (2005-10)

Treg in Sibling Allo Transplant (2004-03)

Unrelated or Partially Matched Related Donor Transplant for Lymphoma, Myeloma, & CLL (MT1999-14)

AHN-12 for NHL (MT2005-14R)

Expanded Human Myeloid Progenitor Cells post Allo UCB for Heme Malignancy (MT2008-38)

CpG after Auto Transplant (MT2003-03)